Fetal bovine bone marrow is a rich source of CD34+ hematopoietic progenitors with myelo-monocytic colony-forming activity

Developmental and Comparative Immunology

Volumn 36, Issue 3, 2012, Pages 572-577

  Pessa Morikawa, Tiina ^a   Niku, Mikael ^a   Iivanainen, Antti ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Aldehyde dehydrogenase; Cattle; CD34; Fetal bone marrow; Flow cytometry; Hematopoiesis; Hematopoietic stem cell

Indexed keywords

ALDEHYDE DEHYDROGENASE; CD11B ANTIGEN; CD14 ANTIGEN; CD2 ANTIGEN; CD34 ANTIGEN; GLYCOPROTEIN;

ANTIGEN EXPRESSION; ARTICLE; BONE MARROW; CELL ISOLATION; CELL POPULATION; CELL SELECTION; CLONOGENESIS; COLONY FORMING CELL; CONTROLLED STUDY; COW; ENZYME ACTIVITY; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; IN VITRO STUDY; LEUKOCYTE; NONHUMAN; PRIORITY JOURNAL;

BOS; BOVINAE; ORYCTOLAGUS CUNICULUS;

EID: 84855860739     PISSN: 0145305X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dci.2011.09.014     Document Type: Article

References (50)

1. Andrews R.G., Singer J.W., Bernstein I.D. Monoclonal antibody 12-8 recognizes a 115-kd molecule present on both unipotent and multipotent hematopoietic colony-forming cells and their precursors. Blood 1986, 67:842-845.
2. Armstrong L., Stojkovic M., Dimmick I., Ahmad S., Stojkovic P., Hole N., Lako M. Phenotypic characterization of murine primitive hematopoietic progenitor cells isolated on basis of aldehyde dehydrogenase activity. Stem Cells 2004, 22:1142-1151.
3. Baum C.M., Weissman I.L., Tsukamoto A.S., Buckle A.M., Peault B. Isolation of a candidate human hematopoietic stem-cell population. Proc. Natl. Acad. Sci. USA 1992, 89:2804-2808.
4. + peripheral blood stem cells in patients with advanced hematologic malignancy. Blood 1996, 88:4132-4138.
5. + marrow cells engraft lethally irradiated baboons. J. Clin. Invest. 1988, 81:951-955.
6. + marrow cells in patients with breast cancer or neuroblastoma. Blood 1991, 77:1717-1722.
7. + cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high-dose VP16, ifosfamide, carboplatin, and epirubicin. Blood 1994, 84:1421-1426.
8. + selected bone marrow grafts are radioprotective and establish mixed chimerism in dogs given high dose total body irradiation. Transplantation 1999, 68:338-344.
9. Charbord P., Tavian M., Humeau L., Peault B. Early ontogeny of the human marrow from long bones: an immunohistochemical study of hematopoiesis and its microenvironment. Blood 1996, 87:4109-4119.
10. Christensen J.L., Wright D.E., Wagers A.J., Weissman I.L. Circulation and chemotaxis of fetal hematopoietic stem cells. PLoS Biol. 2004, 2:E75.
11. Civin C.I., Strauss L.C., Brovall C., Fackler M.J., Schwartz J.F., Shaper J.H. Antigenic analysis of hematopoiesis. III: A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J. Immunol. 1984, 133:157-165.
12. Craig W., Kay R., Cutler R.L., Lansdorp P.M. Expression of Thy-1 on human hematopoietic progenitor cells. J. Exp. Med. 1993, 177:1331-1342.
13. DiGiusto D., Chen S., Combs J., Webb S., Namikawa R., Tsukamoto A., Chen B.P., Galy A.H. Human fetal bone marrow early progenitors for T, B, and myeloid cells are found exclusively in the population expressing high levels of CD34. Blood 1994, 84:421-432.
14. Donahue, R.E., Kuramoto, K., Dunbar, C.E., 2005. Large animal models for stem and progenitor cell analysis. Curr. Protoc. Immunol. Chapter 22, Unit 22A.1.
15. Furness S.G., McNagny K. Beyond mere markers: functions for CD34 family of sialomucins in hematopoiesis. Immunol. Res. 2006, 34:13-32.
16. Gekas C., Dieterlen-Lievre F., Orkin S.H., Mikkola H.K. The placenta is a niche for hematopoietic stem cells. Dev. Cell 2005, 8:365-375.
17. Goodell M.A., Brose K., Paradis G., Conner A.S., Mulligan R.C. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J. Exp. Med. 1996, 183:1797-1806.
18. Goodell M.A., Rosenzweig M., Kim H., Marks D.F., DeMaria M., Paradis G., Grupp S.A., Sieff C.A., Mulligan R.C., Johnson R.P. Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nat. Med. 1997, 3:1337-1345.
19. Hyttel P., Sinowatz F., Vejlsted M. Essentials of Domestic Animal Embryology 2010, Saunders Elsevier, Edinburgh.
20. Jones R.J., Barber J.P., Vala M.S., Collector M.I., Kaufmann S.H., Ludeman S.M., Colvin O.M., Hilton J. Assessment of aldehyde dehydrogenase in viable cells. Blood 1995, 85:2742-2746.
21. Katz F.E., Tindle R., Sutherland D.R., Greaves M.F. Identification of a membrane glycoprotein associated with haemopoietic progenitor cells. Leuk. Res. 1985, 9:191-198.
22. Keller S.L., Wood R.D., Jefferson B.J., Jacobs R.M. Use of a commercial methylcellulose medium with and without recombinant bovine granulocyte colony-stimulating factor for culturing bovine bone marrow cells. Can. J. Vet. Res. 2004, 68:157-159.
23. Kondo M., Wagers A.J., Manz M.G., Prohaska S.S., Scherer D.C., Beilhack G.F., Shizuru J.A., Weissman I.L. Biology of hematopoietic stem cells and progenitors: implications for clinical application. Annu. Rev. Immunol. 2003, 21:759-806.
24. Lange C., Li Z., Fang L., Baum C., Fehse B. CD34 modulates the trafficking behavior of hematopoietic cells in vivo. Stem Cells Dev. 2007, 16:297-304.
25. Layton D.S., Strom A.D., O'Neil T.E., Broadway M.M., Stephenson G.L., Morris K.R., Muralitharan M., Sandrin M.S., Ierino F.L., Bean A.G. Development of an anti-porcine CD34 monoclonal antibody that identifies hematopoietic stem cells. Exp. Hematol. 2007, 35:171-178.
26. Lu L., Xiao M., Shen R.N., Grigsby S., Broxmeyer H.E. Enrichment, characterization, and responsiveness of single primitive CD34 human umbilical cord blood hematopoietic progenitors with high proliferative and replating potential. Blood 1993, 81:41-48.
27. Masauzi N., Tanaka J., Kasai M., Yamada M., Saitoh S., Kawamura T., Tsutsumi Y., Obara S., Matsushima T., Hashino S., Asaka M., Imamura M., Kobayashi M. Mean fluorescence intensity (MFI) of beta2 integrin (CD11a and CD11b) expression on peripheral blood (PB) CD34-positive (CD34(+)) cells in steady state correlates inversely with the total amount of harvested CD34(+) cells. Bone Marrow Transplant. 2003, 31:1069-1070.
28. Mayani H., Lansdorp P.M. Biology of human umbilical cord blood-derived hematopoietic stem/progenitor cells. Stem Cells 1998, 16:153-165.
29. McSweeney P.A., Rouleau K.A., Wallace P.M., Bruno B., Andrews R.G., Krizanac-Bengez L., Sandmaier B.M., Storb R., Wayner E., Nash R.A. Characterization of monoclonal antibodies that recognize canine CD34. Blood 1998, 91:1977-1986.
30. Medvinsky A., Dzierzak E. Definitive hematopoiesis is autonomously initiated by the AGM region. Cell 1996, 86:897-906.
31. Mikkola H.K., Gekas C., Orkin S.H., Dieterlen-Lievre F. Placenta as a site for hematopoietic stem cell development. Exp. Hematol. 2005, 33:1048-1054.
32. Muraguchi A., Kawamura N., Hori A., Horii Y., Ichigi Y., Kimoto M., Kishimoto T. Expression of the CD2 molecule on human B lymphoid progenitors. Int. Immunol. 1992, 4:841-849.
33. Niku M., Pessa-Morikawa T., Ra R., Ekman A., Iivanainen A. Expression of CD34 mRNA and protein in cattle. Vet. Immunol. Immunopathol. 2007, 117:162-172.
34. Osawa M., Hanada K., Hamada H., Nakauchi H. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 1996, 273:242-245.
35. Pearce D.J., Bonnet D. The combined use of Hoechst efflux ability and aldehyde dehydrogenase activity to identify murine and human hematopoietic stem cells. Exp. Hematol. 2007, 35:1437-1446.
36. Porada C.D., Harrison-Findik D.D., Sanada C., Valiente V., Thain D., Simmons P.J., Almeida-Porada G., Zanjani E.D. Development and characterization of a novel CD34 monoclonal antibody that identifies sheep hematopoietic stem/progenitor cells. Exp. Hematol. 2008, 36:1739-1749.
37. Sakurai M., Furusawa T., Ikeda M., Hikono H., Shimizu S., Gotoh H., Kobayashi E., Momotani E. Anti-bovine CD34 monoclonal antibody reveals polymorphisms within coding region of the CD34 gene. Exp. Hematol. 2006, 34:905-913.
38. + peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma. Blood 1995, 86:390-397.
39. Sen J., Arceci R.J., Jones W., Burakoff S.J. Expression and ontogeny of murine CD2. Eur. J. Immunol. 1989, 19:1297-1302.
40. Shpall E.J., Jones R.B., Bearman S.I., Franklin W.A., Archer P.G., Curiel T., Bitter M., Claman H.N., Stemmer S.M., Purdy M. Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. J. Clin. Oncol. 1994, 12:28-36.
41. Sinkora J., Rehakova Z., Sinkora M., Cukrowska B., Tlaskalova-Hogenova H., Bianchi A.T., De Geus B. Expression of CD2 on porcine B lymphocytes. Immunology 1998, 95:443-449.
42. Storms R.W., Trujillo A.P., Springer J.B., Shah L., Colvin O.M., Ludeman S.M., Smith C. Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity. Proc. Natl. Acad. Sci. USA 1999, 96:9118-9123.
43. Trobridge G.D., Kiem H.P. Large animal models of hematopoietic stem cell gene therapy. Gene Ther. 2010, 17:939-948.
44. Uchida N., Fujisaki T., Eaves A.C., Eaves C.J. Transplantable hematopoietic stem cells in human fetal liver have a CD34(+) side population (SP)phenotype. J. Clin. Invest. 2001, 108:1071-1077.
45. Vescio R., Schiller G., Stewart A.K., Ballester O., Noga S., Rugo H., Freytes C., Stadtmauer E., Tarantolo S., Sahebi F., Stiff P., Meharchard J., Schlossman R., Brown R., Tully H., Benyunes M., Jacobs C., Berenson R., DiPersio J., Anderson K., Berenson J. Multicenter phase III trial to evaluate CD34(+) selected versus unselected autologous peripheral blood progenitor cell transplantation in multiple myeloma. Blood 1999, 93:1858-1868.
46. Wagner J.L., Storb R. Preclinical large animal models for hematopoietic stem cell transplantation. Curr. Opin. Hematol. 1996, 3:410-415.
47. Wu A.G., Michejda M., Mazumder A., Meehan K.R., Menendez F.A., Tchabo J.G., Slack R., Johnson M.P., Bellanti J.A. Analysis and characterization of hematopoietic progenitor cells from fetal bone marrow, adult bone marrow, peripheral blood, and cord blood. Pediatr. Res. 1999, 46:163-169.
48. Yoder M.C. Introduction: spatial origin of murine hematopoietic stem cells. Blood 2001, 98:3-5.
49. Zhao Y., Lin Y., Zhan Y., Yang G., Louie J., Harrison D.E., Anderson W.F. Murine hematopoietic stem cell characterization and its regulation in BM transplantation. Blood 2000, 96:3016-3022.
50. Zhong J.F., Zhao Y., Sutton S., Su A., Zhan Y., Zhu L., Yan C., Gallaher T., Johnston P.B., Anderson W.F., Cooke M.P. Gene expression profile of murine long-term reconstituting vs. short-term reconstituting hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 2005, 102:2448-2453.